Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor
Beyond Weight: Cardiometabolic and Organ Effects Weight is the headline endpoint, but both programs have explored effects that matter metabolically
Stepping back from these forecasts, whose methodology is unclear, these are really big changes in consumer market segments larger than $50B
No more waiting for an appointment for the medication I've been taking for quite a while, with much success
Potential side effects of GLP-1s include nausea, vomiting, changes in vision, low blood sugar, and, in rare cases, thyroid cancer
Painful or persistent cramps that present alongside other acute symptoms like swelling, redness, or localized warmth may indicate something more sinister is happening